Health Care & Life Sciences » Pharmaceuticals | Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.
Stock Exchange NASDAQ Stock Market
EPS
$17.64
Market Cap
$7.99 M
Shares Outstanding
6.34 M
Public Float
2.32 M

Profile

Address
509 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.tonixpharma.com
Updated 07/08/2019
Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701.

Financials

View All

Seth Lederman
Chairman, President & Chief Executive Officer
Adeoye Y. Olukotun
Director